Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: Population-based prospective cohort study with 5 years of follow-up

Clinical Infectious Diseases

Volumn 59, Issue 1, 2014, Pages 74-80

  Dang, T T ^a   Eurich, D T ^b   Weir, D L ^b   Marrie, T J ^c   Majumdar, S R ^a,b  

^a Faculty of Medicine and Dentistry   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

community acquired pneumonia; population based cohort; recurrent pneumonia; risk factors

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SURVIVAL; COMMUNITY-ACQUIRED INFECTIONS; MIDDLE AGED; PATHOLOGY; PNEUMONIA; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84903964774     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu247     Document Type: Article

References (33)

1. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20:820-37.
2. Thomas CP, Ryan M, Chapman JD, et al. Incidence and cost of pneumonia in Medicare beneficiaries. CHEST Journal 2012; 142:973-81.
3. Ekdahl K, Braconier JH, Rollof J. Recurrent pneumonia: a review of 90 adult patients. Scand J Infect Dis 1992; 24:71-6.
4. El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004; 52:2010-15.
5. Garcia-Vidal C, Carratala J, Fernandez-Sabe N, et al. Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 2009; 15:1033-8.
6. Winterbauer RH, Bedon GA, Ball JWC. Recurrent pneumonia predisposing illness and clinical patterns in 158 patients. Ann Intern Med 1969; 70:689-700.
7. Eurich DT, Lee C, Marrie TJ, Majumdar SR. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study. Clin Infect Dis 2013; 57:1138-44.
8. Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR. Recurrent community-acquired pneumonia in patients starting acidsuppressing drugs. Am J Med 2010; 123:47-53.
9. Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar SR. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis 2010; 51:15-22.
10. Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 2008; 87:329-34.
11. Eurich DT, Marrie TJ, Johnstone J, Majumdar SR. Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season. Am J Respir Crit Care Med 2008; 178:527-33.
12. Sligl WI, Eurich DT, Marrie TJ, Majumdar SR. Age still matters: prognosticating short- and long-term mortality for critically ill patients with pneumonia. Crit Care Med 2010; 38:2126-32.
13. Majumdar SR, Eurich DT, Gamble JM, Senthilselvan A, Marrie TJ. Oxygen saturations less than 92% are associated with major adverse events in outpatients with pneumonia: a population-based cohort study. Clin Infect Dis 2011; 52:325-31.
14. Skull SA, Andrews RM, Byrnes GB, et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged 65 years. Epidemiol Infect 2008; 136:232-40.
15. Guevara RE, Butler JC, Marston BJ, et al. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999; 149:282-9.
16. van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG. International Classification of Diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007; 60:834-8.
17. Suissa S, Patenaude V, Lapi F, Ernst P. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 2013; 68: 1029-36.
18. Baik I, Curhan GC, Rimm EB, et al. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000; 160:3082-8.
19. Farr BM, Bartlett CLR, Wadsworth J, Miller DL. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. Respir Med 2000; 94:954-63.
20. Gau JT, Acharya U, Khan S, et al. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr 2010; 10:45.
21. Inoue Y, Koizumi A, Wada Y, et al. Risk and protective factors related to mortality from pneumonia among middle aged and elderly community residents: the JACC Study. J Epidemiol 2007; 17:194-202.
22. Molinos L, Clemente MG, Miranda B, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 2009; 58:417-24.
23. Riquelme R, Torres A, El-Ebiary M, et al. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996; 154:1450-5.
24. Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect 2010; 138:1789-95.
25. Torres OH, Munoz J, Ruiz D, et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 2004; 52:1603-9.
26. Trifiro G, Gambassi G, Sen EF, et al. Association of communityacquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 2010; 152:418-25, W139-140.
27. Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 2009; 59:e329-38.
28. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. The Lancet 1987; 329:671-4.
29. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011; 305:822-3.
30. van Hylckama Vlieg A, Christiansen S, Luddington R, et al. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. Br J Haematol 2007; 138:769-74.
31. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368:666-78.
32. Cabre M, Serra-Prat M, Force L, Palomera E, Pallares R. Functional status as a risk factor for mortality in very elderly patients with pneumonia. Med Clin (Barc) 2008; 131:167-70.
33. Basi SK, Marrie TJ, Huang JQ, Majumdar SR. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 2004; 117: 305-11.